Rutgers spinoff success yields $4.3 million payback to university

August 12, 2002

NEW BRUNSWICK/PISCATAWAY, N.J. - The Rutgers spinoff company, Phytomedics Inc., has signed a new research agreement that will bring almost $4.3 million in grant funding from the company to the university during the next five years. Rutgers will use the funding to stimulate research on botanical therapeutics, which include botanical drugs, nutraceuticals and plant-produced novel proteins. Many botanical therapeutics developed through this research will be natural, scientifically designed and optimized mixtures of plant-produced, health-promoting phytochemicals (natural chemicals in plants) that will supplement or substitute for conventional drugs.

"For centuries people have used plants for healing," said Ilya Raskin, Phytomedics co-founder and professor of plant science at Rutgers, The State University of New Jersey. "The 20th century gave us the 'pill option,' which diminished the historical connection between plants and disease treatment, but now, plants are poised for a comeback as sources of human health products."

Phytomedics is a Dayton, N.J.-based life sciences company that grew out of the laboratories and greenhouses at Rutgers. It focuses on human health care and plant biotechnology with the goal of discovering, developing and manufacturing new plant-based pharmaceuticals, botanical drugs and other related products. It is funded by private investors and the New Jersey Commission on Science and Technology. Phytomedics is currently taking a series of botanical drug candidates through clinical and preclinical development. It is also engaged in the manufacture of novel therapeutic proteins in plants. To date, Rutgers has received more than $2 million in grant funding from Phytomedics.

"The new grant from Phytomedics validates Rutgers' efforts to promote commercial ventures through the transfer of technologies produced by university research," said Joseph J. Seneca, university vice president for academic affairs. "These funds will support research and student training while promoting economic development in New Jersey through new business creation and the expansion of agriculture into new and potentially more profitable areas."

Through a comprehensive research and licensing agreement with Rutgers, the results of the funded research are exclusively licensed to Phytomedics for commercial development and relicensing.

Research in botanical therapeutics may add more value to world agriculture than the more conventional application of plant biotechnology for yield enhancement, explained Raskin. "Plants are by far the most abundant and cost-effective renewable resource uniquely adapted to complex biochemical synthesis," he said. "The increasing cost of energy and chemical raw materials, combined with the environmental concerns associated with conventional pharmaceutical manufacturing, will make plants even more desirable as sources for therapeutic agents in the future."

New Jersey farmers who can adapt to growing crops for health, rather than calories can be expected to profit from greater margins and higher values enjoyed by the health industry. Several New Jersey farmers are already growing plants containing botanical therapeutics developed in Raskin's laboratory.
-end-


Rutgers University

Related Health Articles from Brightsurf:

The mental health impact of pandemics for front line health care staff
New research shows the impact that pandemics have on the mental health of front-line health care staff.

Modifiable health risks linked to more than $730 billion in US health care costs
Modifiable health risks, such as obesity, high blood pressure, and smoking, were linked to over $730 billion in health care spending in the US in 2016, according to a study published in The Lancet Public Health.

New measure of social determinants of health may improve cardiovascular health assessment
The authors of this study developed a single risk score derived from multiple social determinants of health that predicts county-level cardiovascular disease mortality.

BU study: High deductible health plans are widening racial health gaps
The growing Black Lives Matter movement has brought more attention to the myriad structures that reinforce racial inequities, in everything from policing to hiring to maternal mortality.

Electronic health information exchange improves public health disease reporting
Disease tracking is an important area of focus for health departments in the midst of the COVID-19 pandemic.

E-health resource improves men's health behaviours with or without fitness facilities
Men who regularly used a free web resource made significantly more health changes than men who did not, finds a new study from the University of British Columbia and Intensions Consulting.

Mental health outcomes among health care workers during COVID-19 pandemic in Italy
Symptoms of posttraumatic stress disorder, depression, anxiety and insomnia among health care workers in Italy during the COVID-19 pandemic are reported in this observational study.

Mental health of health care workers in china in hospitals with patients with COVID-19
This survey study of almost 1,300 health care workers in China at 34 hospitals equipped with fever clinics or wards for patients with COVID-19 reports on their mental health outcomes, including symptoms of depression, anxiety, insomnia and distress.

Health records pin broad set of health risks on genetic premutation
Researchers from the University of Wisconsin-Madison and Marshfield Clinic have found that there may be a much broader health risk to carriers of the FMR1 premutation, with potentially dozens of clinical conditions that can be ascribed directly to carrying it.

Attitudes about health affect how older adults engage with negative health news
To get older adults to pay attention to important health information, preface it with the good news about their health.

Read More: Health News and Health Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.